STUDY OF INDICATORS OF LIFE QUALITY IN PATIENTS WITH ALLERGODERMATOSIS RELATED TO PSYCHOSOMATIC DISORDERS
About the author:	Ya.F. Kutasevych, I.O. Oliinyk, O.M. Stuliy, I.O. Mashtakova,
 V.P. Matiushenko	
Heading	ORIGINAL RESEARCHES	
Type of article	Research Article	
Annotation	The objective: the study of quality of life in patients with allergodermatoses in relation 
to the level of psychosomatic disorders.Materials and methods. There were 142 
patients with allergodermatoses under the supervision. In 84 patients exacerbation of 
chronic eczema was diagnosed, in 58 – atopic dermatitis. The Spielberger–Khanin 
anxiety scale assessed the level of reactive anxiety, andthe Beck scale assessed the
 level of depression. Assessment of the negative impact of the disease on the quality 
of life of patients was carried out by determining the dermatology life quality index
 (DLQI). Results. An examination of 142 patients with allergodermatosis in 123 (86.6%) revealed associated psychoemotional disorders. 87 (61.3%) patients with allergodermatoses had anxious 
disorders, 36 (25.4%) were anxious-depressive. 19 patients with allergodermatoses
 (13.3%) did not have depressive symptoms and had a low level of reactive anxiety 
during hospitalization. When examining the state of reactive anxiety, it was found that
 its high level (average score of 24.8 ± 1.29) was diagnosed in 69 patients (48.6%) with allergodermatoses. 54 patients (38.8%) with allergodermatoses had a moderate level of reactive anxiety 
(17.87 ± 0.67), and 19 patients (13.4%) had a low (average score – 7.08 ± 0.78). 
There was a direct correlation between the level of reactive anxiety and the effect
of allergodermatoses in patients with anxiety disorders on the quality of life. 
Depressive disorders were detected in 36 patients with allergodermatoses. When 
assessing the level of depressive disorders, it was found that 13 patients with allergic 
dermatoses (36.1%) had a mild level of depression, and 23 (63.9%) – moderate. 
A direct dependence of the severity of the degree of depression and the
impact of the disease on the quality of life has been established.
Conclusions. Among 142 patients with allergic dermatosis 123 patients (86.6%) 
showed psychoemotional disorders, of which anxious disorders – in 87 (61.2%) and 
anxiety-depressive – in 36 (25.3%). The dependence of life quality on the degree of 
reactive anxiety and depressive disorders in patients with allergodermatoses has 
been established, which requires the use of psychopharmacotherapeutic agents in 
the complex treatment of allergodermatoses	
Tags	 allergodermatoses, reactive anxiety, depression, life quality	
Bibliography	1.  Adaskevich VP, Dubrova VP. Psihologicheskoe soprovozhdenie patsienta v dermatologii (nekotoryie sovetyi psihologa) (Psychological support of a patient in dermatology (some advice from the psychologist). Rossiyskiy zhurnal kozhnyih i venericheskih bolezney. 2003;1:51–56.
2.  Bryinina AV, Hvorik DF. Rol triggernyih faktorov v patogeneze psoriaza, assotsiirovannogo s kardiovaskulyarnoy patologiey (The role of trigger factors in the pathogenesis of psoriasis associated with cardiovascular disease). Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 
2015;4:10–14.
3.  Dontsova  EV.  Otsenka  psihosomaticheskih  narusheniy  u  bolnyih  atopicheskim  dermatitom i ih dinamika pri provedenii kompleksnogo lecheniya s ispolzovaniem deltarana i nizkointensivnoy lazernoy terapii (Evaluation of psychosomatic disorders in patients with atopic dermatitis and their dynamics during complex treatment using deltaran and low-intensity laser therapy). Vestnik novyih meditsinskih tehnologiy. 2011;2:423–425.
4.  Korolenko VV,  Stepanenko VI.  Mistse  dermatolohii  v  suchasnomu  hlobalnomu  zdorovi  (The place of dermatology in modern global health). Ukrainskyi zhurnal dermatolohii, venerolohii, kosmetolohii. 2015;2:15–16.
5.  Pozdeev  OP.  Otsenka  vliyaniya  atopicheskogo  dermatita  na  kachestvo  zhizni  patsienta (Assessment of the effect of atopic dermatitis on the patient’s life quality). Prakticheskaya meditsina. 
2013;1–4(73):112–113.
6.  Kutasevych YaF, Jafferany M, Sviatenko TV, et al. Psykhodermatolohiia v Ukraini: suchasnyi pohliad na problemu (Psychodermatology in Ukraine: modern view at the problem). Dermatolohiia 
ta venerolohiia. 2018;4(82):8–12.
7.  Smulevich  AV.  Depressii  v  obschey  meditsine  (Depression  in  General  Medicine).  Moscow: Meditsinskoe informatsionnoe agentstvo; 2001. 782 p.
8.  Takiun ChD. Psykhosomatychni aspekty dermatoziv (Psychosomatic aspects of dermatoses).Visnyk KhNPU imeni H. S. Skovorody. Psykholohiia. 2016;53:265–271.
9.  Tamrazova OB, Molochkov AV. Kseroz kozhi –  osnovnoy patogeneticheskiy faktor razvitiya atopicheskogo dermatita (Xerosis of the skin is the main pathogenetic factor in the development of atopic 
dermatitis). Dermatologiya (prilozhenie Consilium Medicum). 2014;4:48–54.
10.  Kanto R, Thysen JP, Pallr AS, et al. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of atopic dermatitis. Allergy. 2016;71(10):1480–1485.
11.  Philbrick KL, Rundell JR, Netzel PJ, Levenson JL. Clinical Manual of Psychosomatic Medicine:A Guide to Consultation-liaison Psychiatry. 2nd ed. Amer Psychiatric Pub; 2011. 564 p.
12.  Jafferany M, Capec S, Yaremkevych R, et al. Effects of family constellation seminars on itch in patients with atopic dermatitis and psoriasis: A patient preference controlled trial. Dermatol. Ther. 
2019;32(6):e13100.
13.  Cork M J, Danby S G, Vasilopoulos Y, еt al. Epidermal barrier dysfunction in atopic dermatitis. J. Dermatol. 2009;129:1892–1908.
14.  Matiushenko V, Kutasevych Y, Jafferany M. Neurotransmitter imbalance in serum of psoriatic patients in exacerbation stage with comorbid psycho-emotional disorders. Dermatol Ther. 2020; Mar 27: e13337.
15.  Nutten  S. Atopic  dermatitis:  global  epidemiology  and  risk  factors.  Ann.  Nutr.  Metab. 2015;66 (1):8–16.
16.  Schut C, Weik U, Tews N, et al. Psychophysiological effects of stress management in patients with atopic dermatitis: a randomized controlled trial. Acta Derm Venereol. 2013;93(1):57–61.	
Publication of the article	«DERMATOLOGY AND VENEREOLOGY» №2(88), 2020 year, 19-23 pages,
 index UDK [616.517: 616.859.4]-08–035	
DOI	10.33743/2308-1066-2020-2-19-23